Skip to content
BiologicalX

Comparison

EGCG vs Hexarelin

Side-by-side of EGCG and Hexarelin. Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.

Effects at a glance

EGCG

  • Modest fat loss (~1.3 kg over 12 weeks) when combined with caffeine and caloric deficit
  • Small reductions in LDL cholesterol (3-6 mg/dL) and systolic blood pressure (2-3 mmHg)
  • EFSA flags hepatotoxicity risk above 800 mg/day, particularly when taken fasted
  • Bioavailability is 0.1-1.0%; gut microbiome variation drives population-variable response
  • Green tea extract typically combines EGCG with caffeine and L-theanine for additive effects
  • Reduces non-heme iron absorption when co-administered with meals

Hexarelin

  • Synthetic hexapeptide GHS-R1a agonist; produces the largest acute GH pulse of the synthetic GHRP class
  • Independent CD36 signaling produces cardioprotective effects in rodent ischemia models, GH-independent
  • Pronounced tachyphylaxis: GH response attenuates over 2 to 4 weeks of daily dosing
  • More cortisol and prolactin elevation than GHRP-2 or ipamorelin
  • Anecdotal protocols use 100 to 200 mcg subcutaneously 1 to 2 times daily for 2 to 4 week pulses
  • Banned by WADA under S2; advanced through phase 2 trials but never reached registration

Side-by-side

Attribute EGCG Hexarelin
Category natural peptide
Also known as epigallocatechin gallate, green tea extract Examorelin, EP-23905, His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2
Half-life (hr) 3 1
Typical dose (mg) 400 0.1
Dosing frequency 1 to 2 times daily with food 1-2x daily
Routes oral subcutaneous, intranasal, intravenous
Onset (hr) 1.5 0.25
Peak (hr) 2 0.5
Molecular weight 458.37 887.04
Molecular formula C22H18O11 C47H58N12O6
Mechanism Inhibits catechol-O-methyltransferase (COMT) to prolong norepinephrine signaling; activates AMPK; scavenges reactive oxygen species via gallate ester; modulates gut microbiome and pancreatic lipase activity. Hexapeptide agonist of GHS-R1a producing acute GH release with cortisol and prolactin co-elevation. Independent CD36 binding produces GH-independent cardioprotective signaling in preclinical models.
Legal status Dietary supplement; warning labels required above 800 mg/day in some EU jurisdictions Not FDA approved; advanced through phase 2 trials in EU but never registered; research-use-only grey market; banned by WADA
WADA status allowed banned
DEA / Rx Not scheduled Not scheduled (research chemical)
Pregnancy Avoid high-dose extracts; moderate green tea consumption appears acceptable Insufficient data; not recommended
CAS 989-51-5 140703-51-1
PubChem CID 65064 3037387
Wikidata Q307091 Q5743550

Safety profile

EGCG

Common side effects

  • nausea
  • abdominal discomfort
  • diarrhea
  • jitteriness (with caffeine)
  • sleep disruption (with caffeine)

Contraindications

  • pregnancy at high-dose extracts
  • active liver disease
  • iron deficiency anemia (separate dosing)

Interactions

  • iron supplements: reduces non-heme iron absorption; separate by 2 to 3 hours(moderate)
  • anticoagulants: additive effects at high catechin doses(minor)
  • beta-blockers (nadolol): reduced absorption when taken simultaneously(moderate)
  • hepatotoxic supplements (high-dose niacin, kava): theoretical additive hepatotoxicity at high EGCG doses(moderate)
  • stimulants and caffeine: additive thermogenic and cardiovascular effects(minor)

Hexarelin

Common side effects

  • water retention
  • vivid dreams
  • head pressure or flushing
  • transient lethargy
  • tingling at injection site
  • moderate hunger

Contraindications

  • pregnancy
  • active malignancy
  • history of pituitary tumor
  • uncontrolled diabetes
  • prolactin-sensitive states

Interactions

  • CJC-1295: synergistic GH release; accelerates tachyphylaxis if used continuously(minor)
  • sermorelin: additive GH release via parallel GHRH and ghrelin pathways(minor)
  • insulin: sustained GH can blunt insulin sensitivity over weeks(moderate)
  • corticosteroids: amplify cortisol load; blunt GH response(moderate)

Which Should You Take?

EGCG comes out ahead for most readers on the criteria we weight: 3 catalogued goals, OTC dietary supplement, oral dosing, with a Tier-B outcome catalogued. Hexarelin is the right call when one of the conditionals below applies.

  • If your priority is metabolic health and glucose control, pick EGCG.
  • If your priority is healthspan extension, pick EGCG.
  • If your priority is growth-hormone axis, pick Hexarelin.
  • If your priority is post-training recovery, pick Hexarelin.

Edge case: If you want to avoid research-only / gray-market sourcing, EGCG is the more accessible choice.

Default choice: EGCG. Lower friction to source, and broader goal coverage. Reach for Hexarelin only if your priority sits squarely in the goals it owns above.

This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.

Common questions

What is the difference between EGCG and Hexarelin?

EGCG and Hexarelin differ in category (natural vs peptide), mechanism, and typical dosing. See the side-by-side table for full details.

Which has a longer half-life, EGCG or Hexarelin?

EGCG half-life is 3 hours; Hexarelin half-life is 1 hours.

Can you stack EGCG with Hexarelin?

Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.

Go deeper